Stefan H. Heinemann's OpenAlex profile lists 480 works, ~19,162 citations, and an h-index of 71, with sustained output from the late 1980s through 2026 . His canonical contributions include first-author mapping of sodium-channel selectivity determinants and senior/middle-author work on K+ channel Ξ²-subunit inactivation, C-type inactivation, and hERG β foundational electrophysiology with hundreds of citations each. This is a career built on mechanistic, quantitative biophysics rather than trend-driven output.
The 2026 bioRxiv preprint on bioelectric contact inhibition exemplifies his current program: engineering the red-shifted voltage indicator rEstus2s (V1/2 β58.3 Β± 1.3 mV; ~4.6-fold brightness change over β100 to 0 mV), demonstrating Ca2+-activated oncochannel-driven Vm volatility, and showing that gap junctions (Cx43/Cx45) passively damp Vm variance with a predicted 1/n scaling validated for 1-, 2-, and 8-cell clusters . Strengths: proper genetic perturbation (KO plus rescue), pharmacological controls, falsification criteria, deposited reagents (Addgene 250991). Weaknesses: entirely in vitro; 1/n law untested beyond 8 cells; FFCA is an indirect coupling readout.
A second 2026 preprint reports that Kir2.1 channels functionally interfere with ASAP-type voltage sensors via a hydrophobic interface, with ΞF of rEstus-NI dropping from 0.78 Β± 0.01 (n = 24) to 0.36 Β± 0.05 (n = 19), mitigated by the A79W mutation . Critically, the authors themselves acknowledge no direct biochemical or structural validation of the proposed complex β an honest but significant gap. This candor about limitations is a consistent epistemic strength across both 2026 papers.
Reported (ΞF0 β ΞF)/ΞF0 values for six GEVIs co-expressed with mKir2.1 in HEK293T cells, from the 2026 Kir2.1 co-assembly preprint .
Across the reviewed corpus, Heinemann's work shows: appropriate controls and n-reporting, quantified uncertainty, explicit falsification criteria, and self-stated limitations (e.g., structural claims without direct evidence in the Kir2.1 paper; heterologous HEK293 expression not reflecting native contexts). A 2012 JGP paper on scorpion Ξ²-toxin bimodality likewise supported mechanistic claims with domain-swaps, point mutations, and noise analysis . Remaining risks: overexpression artifacts, reliance on HEK293 heterologous systems, and structural interpretations currently extrapolated from AlphaFold 3/MD rather than experiment. Confidence in the overall verdict: high, based on direct full-text evidence for recent papers and robust bibliometric data.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.